Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ART Advanced Research Technologies Ships First of Two Optix Systems to U.S. National Cancer Institute
- ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that it has shipped the first of two Optix® MX2 units ordered by the National Cancer Institute - Frederick (NCI-Frederick), in...
- Research articles 2008-09-17
- Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
- To: FOREIGN EDITORS Contact: Michael W. Rogers, Executive Vice President and CFO, +1- 781-861-8444, or Brooke D. Wagner, VP, Corp. Communications, +1-781- 402-3410, both of Indevus Pharmaceuticals, Inc. LEXINGTON, Mass., April 3, 2008 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced the signing of a License, Supply and...
- Research articles 2008-04-03
Additional Resources
- US DEPT OF HHS: The National Cancer Institute pu publishes new Atlas of Cancer Mortality.
- M2 PRESSWIRE-9 December 1999-US DEPT OF HHS: The National Cancer Institute publishes new Atlas of Cancer Mortality C1994-99 M2 COMMUNICATIONS LTD RDATE:091299 The National Cancer Institute NCI has published a new atlas, the "Atlas of Cancer Mortality in the United States,...
- Research articles 1999-12-09
- Big grant will back cancer research.(National Cancer Institute grant to Case Western Reserve University and Universtiy Hospitals of Cleveland for colon cancer research)(Brief Article)
- Researchers at Case Western Reserve University and University Hospitals of Cleveland have received a $6.7 million grant from the National Cancer Institute to identify the genes that cause colon cancer to spread. Using "gene chip" technol Researchers at Case Western Reserve University and...
- Research articles 2000-10-09
- Biomaterials and the NCI Alliance for Nanotechnology in Cancer.(OBSERVATIONS)(National Cancer Institute)
- Several years ago the National Cancer Institute made a major commitment to bringing advances in contemporary nanotechnology to bear on issues in cancer research, diagnosis, and treatment. A key part of this effort was the establishment in September 2 Several years ago the National Cancer Institute...
- Research articles 2007-04-01
- Cypress Systems Inc.(signs agreement with National Cancer Institute)(Brief Article)
- CYPRESS Systems Inc., a Fresno, Calif.-based biotechnology company, has signed a clinical trial agreement with the National Cancer Institute's Division of Cancer Prevention to promote the use of Cypress's SelenoExcell ... CYPRESS Systems Inc., a Fresno, Calif.-based biotechnology company, has signed a clinical...
- Research articles 2000-02-07
- Roche Vitamins.(provides National Cancer Institute with vitamin E)(Brief Article)
- Roche Vitamins, Parsippany, N.J., will provide vitamin E for a 12-year trial conducted by the National Cancer Institute. The Selenium and Vitamin E Cancer Prevention Trial SELECT will study the ability of the vitamins by themselves and in combinati Roche Vitamins, Parsippany, N.J., will provide vitamin...
- Research articles 2001-09-01
- CWA: Politics Sours Science at National Cancer Institute; Link Between Abortion, Breast Cancer Deserves Real Scientific Inquiry
- WASHINGTON, March 4 /U.S. Newswire/ -- Sandy Rios, president of Concerned Women for America, warned the National Cancer Institute NCI not to post misinformation on the agency Web site denying the link between abortion and breast cancer. "The National Cancer Institute has decided that protecting women's health is less important...
- Research articles 2003-03-04
- Endeca Selected by the National Cancer Institute to Power Search of Web's Most Comprehensive Collection of Cancer Information
- CAMBRIDGE, Mass. -- Endeca, the leading provider of Guided NavigationR, Search and Analysis solutions announced today that the National Cancer Institute NCI, part of the U.S. National Institutes of Health, has selected and deployed the Endeca ProFindTM search and navigation platform on its award-winning website, Cancer.gov (www.cancer.gov). Using the new...
- Research articles 2005-04-11
- US National Cancer Institute
- Celera Genomics has signed its most symbolically important deal to date, with the US National Cancer Institute. This institute is the largest part of the National Institutes of Health in Bethesda, Maryland, which heads the public Human Genome Project -- Celera's rival in the race to sequence the entire human...
- Research articles 2001-07-16
- The National Cancer Institute intends to award a five-year contract to provide total professional and logistical support for the NCI Exhibit Program.(Procurement Watch)(Brief Article)
- The National Cancer Institute intends to award a rive-year contract to provide total professional and logistical support for the NCI Exhibit Program. This is a full and ... The National Cancer Institute intends to award a rive-year contract to provide total professional and logistical support for...
- Research articles 2004-02-20
- The National Cancer Institute intends to award a five-year contract to provide professional and logistical support for the NCI Exhibit Program.(Procurement Watch)
- The National Cancer Institute intends to award a five-year contract to provide professional and logistical support for the NCI Exhibit Program. The agency will use a cascading evaluation preference, with HUBZone firms ... The National Cancer Institute intends to award a five-year contract to provide...
- Research articles 2004-03-05
- The City College of New York Biomedical Engineering Department received a $750,000 grant from the National Cancer Institute to conduct cancer research and training activities in partnership with Memorial Sloan-Kettering Cancer Center
- The City College of New York Biomedical Engineering Department received a $750,000 grant from the National Cancer Institute to conduct cancer research and training activities in partnership with Memorial Sloan-Kettering Cancer Center. The grant will fund two pilot projects: one to understand the role of permeability of blood vessels in...
- Research articles 2005-12-01
- National Cancer Institute Supports Development of Niadyne's Pro-NAD Compound as a New Candidate Skin Cancer Preventive Agent
- Business Editors & Health/Medical Writers First Compound to Receive NCI RAPID Award for Study as Skin Cancer Preventive Agent Pro-NADTM, a patented derivative of niacin developed by two University of Arizona College of Pharmacy professors, will undergo testing supported by the National Cancer Institute NCI to evaluate...
- Research articles 2002-07-01
- Sophic Systems Alliance Receives Award from National Cancer Institute to Complete the Cancer Gene Index Project
- FALMOUTH, Mass. -- Today, Sophic announced the launch of a 12-month, $1.3M project funded by the National Cancer Institute NCI, to complete the first comprehensive index of 6,610 cancer-related genes found in Medline abstracts, with manually annotated gene-disease and gene-compound relationships. Over the past four years, Sophic has teamed with...
- Research articles 2008-06-24
- National Cancer Institute awards Matritech research grant for prostate cancer therapy
- CAMBRIDGE, Mass.--BUSINESS WIRE--Jan. 24, 1995--Matritech Inc. (NASDAQ: NMPS, BSE: MPS), a biotechnology company developing products based upon cancer-specific nuclear matrix proteins, today announced that the National Cancer Institute has awarded Matritech a Small Business Innovative Research SBIR grant of $88,000 to clone the gene that expresses "PC-1," a prostate cancer-specific...
- Research articles 1995-01-24
- National Cancer Institute awards Matritech research grant for colon cancer test
- CAMBRIDGE, Mass.--BUSINESS WIRE--March 28, 1995--Matritech Inc. (NASDAQ: NMPS, BSE: MPS), a biotechnology company developing novel and proprietary diagnostic and therapeutic products based upon cancer-specific nuclear matrix proteins, today announced that the National Cancer Institute NCI has awarded Matritech a "Small Business Innovative Research" SBIR grant of $100,000 to establish the...
- Research articles 1995-03-28
- ImClone Systems Awarded Grant by National Cancer Institute for Program in Cancer-Related Angiogenesis
- NEW YORK--BW HealthWire--Nov. 11, 1997--ImClone Systems Incorporated (Nasdaq:IMCL) announced today that the Company has received from the National Cancer Institute NCI a Phase I Small Business Innovation Research SBIR grant of $100,000 to support preclinical research on the validation of vascular-specific cadherin (VE-cadherin) as a novel potential drug target to...
- Research articles 1997-11-11
- Lorus Therapeutics Broadens Collaboration with the U.S. National Cancer Institute; U.S. NCI to Test Novel Compounds for In Vivo Anti-Cancer Efficacy in Animal Models
- TORONTO--BUSINESS WIRE--March 8, 1999--Lorus Therapeutics (TSE:LOR.) (ME:LOR.) (Nasdaq:LORFF) Lorus Therapeutics Inc, on behalf of its 80 percent-owned subsidiary NuChem Pharmaceuticals Inc., today announced independent confirmation by the U.S. National Cancer Institute ("NCI") of the in vitro anti-cancer activity of its novel compounds currently under development.
- Research articles 1999-03-08
- SRI International Awarded National Cancer Institute Contract to Evaluate Potential Cancer Drugs
- SRI International, an independent nonprofit research and development organization, today announced that it has been awarded a $7.9 million contract by the National Cancer Institute NCI to conduct analytical chemistry evaluations of anti-cancer drugs and dosage formulations. The new contract, which was awarded to SRI by the NCI's Pharmaceutical...
- Research articles 2007-10-25
- << Previous
- page 1 of 1
- Next >>
Presented by American Express